Amring Pharmaceuticals Inc. Sustainability Profile
Amring Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a focus on therapeutic areas such as pain management and infectious diseases, Amring is dedicated to providing innovative solutions that meet the evolving needs of healthcare providers and patients. The company’s core products include a range of injectable medications, which are distinguished by their rigorous quality standards and commitment to safety. Amring's strategic operational regions extend across North America, allowing it to effectively serve a diverse market. Notable achievements include securing FDA approvals for several key products, reinforcing its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Amring Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amring Pharmaceuticals Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amring Pharmaceuticals Inc.'s reported carbon emissions
Amring Pharmaceuticals Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that Amring Pharmaceuticals Inc. is a current subsidiary, and any potential emissions data or climate commitments may be cascaded from its parent organisation. However, no specific information regarding such data or initiatives has been provided. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. While Amring Pharmaceuticals Inc. has not disclosed its own commitments, the industry as a whole is moving towards more transparent reporting and ambitious climate goals.
How Carbon Intensive is Amring Pharmaceuticals Inc.'s Industry?
How Carbon Intensive is Amring Pharmaceuticals Inc.'s Location?
Amring Pharmaceuticals Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amring Pharmaceuticals Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
